Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Eicosanoid Synthesis WP167,0.019696063742573877,6.610327022375215,25.960978414915733,"['TBXAS1', 'PLA2G5', 'PTGDS']",0.9881408020228055,0,0,3
2,Methionine De Novo and Salvage Pathway WP3580,0.025634145913063795,4.115480498592682,15.078420880265982,"['AHCY', 'CHDH', 'ODC1', 'MTR']",0.9881408020228055,0,0,4
3,T-Cell Receptor and Co-stimulatory Signaling WP2583,0.025634145913063795,4.115480498592682,15.078420880265982,"['DYRK1A', 'NFATC2', 'RASGRP1', 'PDK1']",0.9881408020228055,0,0,4
4,Dopaminergic Neurogenesis WP2855,0.02587401859545804,5.783584337349398,21.136201248306442,"['NR4A2', 'ALDH1A1', 'GLI1']",0.9881408020228055,0,0,3
5,Sleep regulation WP3591,0.030536818685683708,3.8579613992762365,13.459741196719303,"['OXTR', 'AHCY', 'ADORA1', 'PTGDS']",0.9881408020228055,0,0,4
6,Osteoblast Signaling WP322,0.032908532116587036,10.27356598475732,35.07419385133134,"['PDGFRB', 'BGLAP']",0.9881408020228055,0,0,2
7,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.04095618850386546,4.626144578313253,14.781699366223426,"['RAB27A', 'SYTL3', 'UNC13D']",0.9881408020228055,0,0,3
8,Sulfation Biotransformation Reaction WP692,0.04738970185292577,7.704572803850782,23.493941655618748,"['SULT1A1', 'GSR']",0.9881408020228055,0,0,2
9,Prostaglandin Synthesis and Regulation WP98,0.04834252064037864,3.2480477430004444,9.839777970717074,"['CBR1', 'CYP11A1', 'TBXAS1', 'PTGDS']",0.9881408020228055,0,0,4
10,Type I collagen synthesis in the context of Osteogenesis imperfecta WP4786,0.04834252064037864,3.2480477430004444,9.839777970717074,"['SERPINH1', 'P3H2', 'PLOD2', 'TMEM38B']",0.9881408020228055,0,0,4
11,Phosphoinositides metabolism WP4971,0.05442072288110597,2.375592968095991,6.915375509277839,"['MTMR10', 'MTMR12', 'INPP5D', 'PLCE1', 'PLCD4', 'PLCD1']",0.9881408020228055,0,0,6
12,White fat cell differentiation WP4149,0.05531266833275498,3.0854041013269,8.93148374399626,"['CTNNA1', 'RORA', 'KLF4', 'KLF2']",0.9881408020228055,0,0,4
13,Constitutive Androstane Receptor Pathway WP2875,0.05954196795766175,3.8545180722891565,10.873880219966377,"['SULT1A1', 'NCOA1', 'DNAJC7']",0.9881408020228055,0,0,3
14,MAPK pathway in congenital thyroid cancer WP4928,0.05954196795766175,3.8545180722891565,10.873880219966377,"['ALK', 'GAREM2', 'SHC1']",0.9881408020228055,0,0,3
15,Arylamine metabolism WP694,0.061061200337903854,inf,inf,['SULT1A1'],0.9881408020228055,0,0,1
16,Amino Acid metabolism WP3925,0.06250859910152648,1.99366568914956,5.527340724781857,"['GLUD1', 'MAOA', 'RARS', 'ALDH1A1', 'ODC1', 'GSR', 'FAH', 'FARSB']",0.9881408020228055,0,0,8
17,Ketogenesis and Ketolysis WP4742,0.06370810755418796,6.163176895306859,16.969959037286333,"['CPT2', 'OXCT1']",0.9881408020228055,0,0,2
18,Role of Osx and miRNAs in tooth development WP3971,0.06370810755418796,6.163176895306859,16.969959037286333,"['NOTCH2', 'KLF4']",0.9881408020228055,0,0,2
19,Eicosanoid metabolism via cyclooxygenases (COX) WP4719,0.07007086063873298,3.5577386468952734,9.457352546719768,"['TBXAS1', 'PLA2G5', 'PTGDS']",0.9881408020228055,0,0,3
20,One-carbon metabolism WP241,0.07077717510145752,2.8044741747998683,7.426860997773909,"['MTFMT', 'AHCY', 'CHDH', 'MTR']",0.9881408020228055,0,0,4
21,Ciliary landscape WP4352,0.07410817495421165,1.498871957253117,3.900408718211151,"['NEK8', 'WDR26', 'INTU', 'TFAP2E', 'EIPR1', 'ARMC8', 'IQGAP1', 'BBIP1', 'DCAF7', 'LRPPRC', 'EXOSC7', 'AFG3L2', 'MSH2', 'EXOSC9', 'XPNPEP3', 'CDH23', 'MCM5', 'SNAP29']",0.9881408020228055,0,0,18
22,Urea cycle and metabolism of amino groups WP497,0.08137091678324157,3.303356282271945,8.287253310439059,"['GLUD1', 'ACY1', 'ODC1']",0.9881408020228055,0,0,3
23,Nuclear receptors WP170,0.08820685549634177,2.5703659026940087,6.241029859715298,"['NR4A2', 'NR4A1', 'THRB', 'RORA']",0.9881408020228055,0,0,4
24,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.0956733693878421,2.0129856474423007,4.7241054980966615,"['RSAD2', 'SP3', 'PLCE1', 'ISG15', 'IFI44L', 'PLCD1']",0.9881408020228055,0,0,6
25,Zinc homeostasis WP3529,0.09762495694931364,2.4673582629674304,5.740610292358696,"['SLC30A9', 'SLC39A11', 'SLC30A1', 'SLC39A12']",0.9881408020228055,0,0,4
26,Folate-Alcohol and Cancer Pathway Hypotheses WP1589,0.10077245387604468,4.401581571256662,10.101146569648382,"['ALDH1A1', 'MTR']",0.9881408020228055,0,0,2
27,Methionine metabolism leading to sulfur amino acids and related disorders WP4292,0.10077245387604468,4.401581571256662,10.101146569648382,"['AHCY', 'MTR']",0.9881408020228055,0,0,2
28,NLR Proteins WP288,0.10077245387604468,4.401581571256662,10.101146569648382,"['ERBIN', 'EPHB2']",0.9881408020228055,0,0,2
29,PKC-gamma calcium signaling pathway in ataxia WP4760,0.10610313368486318,2.889984939759036,6.48322950364868,"['CACNA1A', 'ATP2B2', 'PDK1']",0.9881408020228055,0,0,3
30,NRF2 pathway WP2884,0.10840527874648544,1.6746695519943853,3.7209122625331026,"['CBR1', 'SLC6A9', 'FTH1', 'TXNRD1', 'GSR', 'SLC39A11', 'SLC39A12', 'SLC5A3', 'PRDX6']",0.9881408020228055,0,0,9
31,Alzheimer's disease WP2059,0.11999346276050833,1.7710475131981105,3.7551839470877795,"['BACE1', 'PPP3CB', 'CAPN2', 'EIF2AK3', 'ADAM10', 'CACNA1D', 'MAPT']",0.9881408020228055,0,0,7
32,15q13.3 copy number variation syndrome WP4942,0.12104156726082332,3.851083032490975,8.132028810430006,"['MTMR10', 'SERPINH1']",0.9881408020228055,0,0,2
33,Development and heterogeneity of the ILC family WP3893,0.12104156726082332,3.851083032490975,8.132028810430006,"['IL33', 'RORA']",0.9881408020228055,0,0,2
34,Iron metabolism in placenta WP2007,0.12104156726082332,3.851083032490975,8.132028810430006,"['FTH1', 'ACO1']",0.9881408020228055,0,0,2
35,TCA cycle in senescence WP5050,0.12104156726082332,3.851083032490975,8.132028810430006,"['ME2', 'PDK1']",0.9881408020228055,0,0,2
36,Trans-sulfuration pathway WP2333,0.12104156726082332,3.851083032490975,8.132028810430006,"['AHCY', 'MTR']",0.9881408020228055,0,0,2
37,EPO Receptor Signaling WP581,0.13335250078477373,2.568473895582329,5.174856603689954,"['SHC1', 'IRS1', 'PDK1']",0.9881408020228055,0,0,3
38,DNA Repair Pathways Full Network WP4946,0.13435226089666305,1.544228432563791,3.099714468996972,"['DDB1', 'POLD3', 'RFC3', 'RAP1A', 'MSH2', 'PRKDC', 'FANCC', 'HMGB1', 'GTF2H3', 'RAD54B']",0.9881408020228055,0,0,10
39,GPR40 Pathway WP3958,0.1421899244716846,3.4229175023398852,6.676714191746474,"['PLCE1', 'PLCD1']",0.9881408020228055,0,0,2
40,Homologous recombination WP186,0.1421899244716846,3.4229175023398852,6.676714191746474,"['POLD3', 'RAD54B']",0.9881408020228055,0,0,2
41,Leptin Insulin Overlap WP3935,0.1421899244716846,3.4229175023398852,6.676714191746474,"['IRS1', 'LEPR']",0.9881408020228055,0,0,2
42,miR-509-3p alteration of YAP1/ECM axis WP3967,0.1421899244716846,3.4229175023398852,6.676714191746474,"['COL5A1', 'TEAD1']",0.9881408020228055,0,0,2
43,DNA Mismatch Repair WP531,0.1477941640125139,2.433100824350032,4.651930033249616,"['POLD3', 'RFC3', 'MSH2']",0.9881408020228055,0,0,3
44,DNA Replication WP466,0.15103247592131597,2.055327704061118,3.8851045535511477,"['POLD3', 'RFC3', 'ORC3', 'MCM5']",0.9881408020228055,0,0,4
45,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.1571948328637084,1.8356050149528411,3.3963635498338127,"['DDX17', 'TRAF3', 'DHX58', 'TRIM25', 'ISG15']",0.9881408020228055,0,0,5
46,Oxidative Stress WP408,0.16271191589185727,2.311265060240964,4.19673507055134,"['MAOA', 'TXNRD1', 'GSR']",0.9881408020228055,0,0,3
47,Photodynamic therapy-induced unfolded protein response WP3613,0.16271191589185727,2.311265060240964,4.19673507055134,"['DNAJB11', 'EIF2AK3', 'CALR']",0.9881408020228055,0,0,3
48,Activation of NLRP3 Inflammasome by SARS-CoV-2 WP4876,0.1722379293587229,7.696514423076923,13.537233342206706,['TRAF3'],0.9881408020228055,0,0,1
49,Amino Acid Metabolism Pathway Excerpt (Histidine catabolism extension) WP4661,0.1722379293587229,7.696514423076923,13.537233342206706,['GLUD1'],0.9881408020228055,0,0,1
50,EV release from cardiac cells and their functional effects WP3297,0.1722379293587229,7.696514423076923,13.537233342206706,['KLF2'],0.9881408020228055,0,0,1
51,Fatty Acid Omega Oxidation WP206,0.1722379293587229,7.696514423076923,13.537233342206706,['ALDH1A1'],0.9881408020228055,0,0,1
52,Hypothetical Craniofacial Development Pathway WP3655,0.1722379293587229,7.696514423076923,13.537233342206706,['ARHGAP29'],0.9881408020228055,0,0,1
53,let-7 inhibition of ES cell reprogramming WP3299,0.1722379293587229,7.696514423076923,13.537233342206706,['KLF4'],0.9881408020228055,0,0,1
54,MED and Pseudoachondroplasia genes WP4789,0.1722379293587229,7.696514423076923,13.537233342206706,['COL9A2'],0.9881408020228055,0,0,1
55,Hedgehog Signaling Pathway WP4249,0.17495108730625838,1.926568154402895,3.3584877104263513,"['GRK3', 'FBXL17', 'GLI1', 'CSNK1G1']",0.9881408020228055,0,0,4
56,Focal Adhesion WP306,0.17550139417044766,1.393056331449818,2.4240688737413802,"['VASP', 'PDGFRB', 'RAP1A', 'PPP1R12A', 'SHC1', 'COL5A2', 'CAPN2', 'TESK2', 'ITGA7', 'PARVB', 'TLN1', 'MYLK']",0.9881408020228055,0,0,12
57,Hypertrophy Model WP516,0.18641285970795554,2.8001312766655726,4.703636407342651,"['NR4A3', 'ADAM10']",0.9881408020228055,0,0,2
58,Ethanol effects on histone modifications WP3996,0.19377208855327244,2.1008214676889376,3.4476005729279824,"['AHCY', 'ALDH1A1', 'MTR']",0.9881408020228055,0,0,3
59,Resistin as a regulator of inflammation WP4481,0.19377208855327244,2.1008214676889376,3.4476005729279824,"['PLCE1', 'PLCD4', 'PLCD1']",0.9881408020228055,0,0,3
60,Integrin-mediated Cell Adhesion WP185,0.2066919948242237,1.4991760828625236,2.3634893858676995,"['VASP', 'RAP1A', 'SHC1', 'CAPN5', 'CAPN2', 'ITGA7', 'TLN1']",0.9881408020228055,0,0,7
61,Cysteine and methionine catabolism WP4504,0.20917749392303686,2.5665864420377056,4.015609627249613,"['AHCY', 'MTR']",0.9881408020228055,0,0,2
62,Type II diabetes mellitus WP1584,0.20917749392303686,2.5665864420377056,4.015609627249613,"['IRS1', 'CACNA1A']",0.9881408020228055,0,0,2
63,Hematopoietic Stem Cell Differentiation WP2849,0.20981490615277404,2.009324253535883,3.1376191696950895,"['THRB', 'MXI1', 'NFATC2']",0.9881408020228055,0,0,3
64,Somatic sex determination WP4814,0.2227933136689829,5.1306089743589745,7.703664692413817,['PTGDS'],0.9881408020228055,0,0,1
65,Synthesis and Degradation of Ketone Bodies WP311,0.2227933136689829,5.1306089743589745,7.703664692413817,['OXCT1'],0.9881408020228055,0,0,1
66,Tamoxifen metabolism WP691,0.2227933136689829,5.1306089743589745,7.703664692413817,['SULT1A1'],0.9881408020228055,0,0,1
67,The alternative pathway of fetal androgen synthesis WP4524,0.2227933136689829,5.1306089743589745,7.703664692413817,['CYP11A1'],0.9881408020228055,0,0,1
68,Melatonin metabolism and effects WP3298,0.22613519849940808,1.9254518072289157,2.862419469289007,"['SULT1A1', 'MAOA', 'CRY2']",0.9881408020228055,0,0,3
69,MFAP5 effect on permeability and motility of endothelial cells via cytoskeleton rearrangement WP4560,0.2321983479438211,2.3689715819679718,3.45908542087191,"['LPP', 'MYLK']",0.9881408020228055,0,0,2
70,Mitochondrial complex III assembly WP4921,0.2321983479438211,2.3689715819679718,3.45908542087191,"['UQCR10', 'UQCRC2']",0.9881408020228055,0,0,2
71,ATM Signaling Network in Development and Disease  WP3878,0.23950941366180672,1.665569067257849,2.3803689477324226,"['RNF20', 'PRKDC', 'PPM1D', 'HMGN1']",0.9881408020228055,0,0,4
72,Ciliopathies WP4803,0.24469663293403987,1.2855257815671945,1.8096810098318412,"['NEK8', 'INTU', 'XPNPEP3', 'NME9', 'EFHC1', 'CEP83', 'PKD1L1', 'BBIP1', 'CEP41', 'WDR35', 'TOPORS', 'GLIS2']",0.9881408020228055,0,0,12
73,miRNA targets in ECM and membrane receptors WP2911,0.2553594196514144,2.199587416193914,3.0026199110238325,"['COL5A1', 'COL5A2']",0.9881408020228055,0,0,2
74,Pregnane X receptor pathway WP2876,0.2553594196514144,2.199587416193914,3.0026199110238325,"['NCOA1', 'DNAJC7']",0.9881408020228055,0,0,2
75,Triacylglyceride synthesis WP325,0.2553594196514144,2.199587416193914,3.0026199110238325,"['AGPAT3', 'PLPP1']",0.9881408020228055,0,0,2
76,Pathways affected in adenoid cystic carcinoma WP3651,0.2556494582175822,1.5106090745476934,2.060392341864826,"['PRKDC', 'NFIB', 'ATRX', 'ERBIN', 'DTX4']",0.9881408020228055,0,0,5
77,VEGFA-VEGFR2 Signaling Pathway WP3888,0.25971362436375073,1.1639602751288545,1.569222958411745,"['SHC1', 'AP2A1', 'PLA2G5', 'IQGAP1', 'HMGB1', 'RAP1A', 'CSRP1', 'DHX36', 'CTNNA1', 'CAPN2', 'EPHB2', 'EIF2AK3', 'NFATC2', 'LARP7', 'ADAM10', 'PDE4DIP', 'PRDX6', 'NR4A2', 'MOV10', 'GLUD1', 'NR4A1', 'TFCP2', 'NR4A3', 'TPP1', 'CALR', 'FARSB']",0.9881408020228055,0,0,26
78,Classical pathway of steroidogenesis with glucocorticoid and mineralocorticoid metabolism WP4523,0.27026451819507447,3.84765625,5.034096839908435,['CYP11A1'],0.9881408020228055,0,0,1
79,Molybdenum cofactor (Moco) biosynthesis WP4507,0.27026451819507447,3.84765625,5.034096839908435,['GPHN'],0.9881408020228055,0,0,1
80,NAD Biosynthesis II (from tryptophan) WP2485,0.27026451819507447,3.84765625,5.034096839908435,['NADSYN1'],0.9881408020228055,0,0,1
81,Nucleotide GPCRs WP80,0.27026451819507447,3.84765625,5.034096839908435,['ADORA1'],0.9881408020228055,0,0,1
82,Serotonin Transporter Activity WP1455,0.27026451819507447,3.84765625,5.034096839908435,['MAOA'],0.9881408020228055,0,0,1
83,Vitamin D Metabolism WP1531,0.27026451819507447,3.84765625,5.034096839908435,['CYP27A1'],0.9881408020228055,0,0,1
84,Nucleotide Excision Repair WP4753,0.2805517022327297,1.5402895054282268,1.9577037245545532,"['POLD3', 'DDB1', 'RFC3', 'GTF2H3']",0.9881408020228055,0,0,4
85,Vitamin D-sensitive calcium signaling in depression WP4698,0.29329062815207657,1.64987091222031,2.0237172354841246,"['CYP27A1', 'GSR', 'ATP2B2']",0.9881408020228055,0,0,3
86,Regulation of Actin Cytoskeleton WP51,0.29407097259522663,1.2726017636055937,1.5575807417814371,"['CYFIP2', 'PDGFRB', 'ENAH', 'PPP1R12A', 'MRAS', 'MYL3', 'IQGAP1', 'MYLK', 'ARHGEF6']",0.9881408020228055,0,0,9
87,Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301,0.3017029349289704,1.924338146811071,2.305958272532593,"['MRAS', 'RAB27A']",0.9881408020228055,0,0,2
88,Mesodermal commitment pathway WP2857,0.3020466694852104,1.2841414141414143,1.537340377950637,"['EPB41L5', 'SESN1', 'UBR5', 'HMGA2', 'KLF4', 'TEAD1', 'PIAS1', 'PARP8']",0.9881408020228055,0,0,8
89,Aspirin and miRNAs WP4707,0.3148394822033179,3.0778846153846153,3.557087705240255,['PDK1'],0.9881408020228055,0,0,1
90,EDA signaling in hair follicle development WP3930,0.3148394822033179,3.0778846153846153,3.557087705240255,['GLI1'],0.9881408020228055,0,0,1
91,Genes targeted by miRNAs in adipocytes WP1992,0.3148394822033179,3.0778846153846153,3.557087705240255,['PTBP2'],0.9881408020228055,0,0,1
92,Peroxiredoxin 2 induced ovarian failure WP4873,0.3148394822033179,3.0778846153846153,3.557087705240255,['CYP11A1'],0.9881408020228055,0,0,1
93,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.3247146738431905,1.8110002123593119,2.0370282673670057,"['H2AFY', 'H2AFY2']",0.9881408020228055,0,0,2
94,Genes controlling nephrogenesis WP4823,0.3247146738431905,1.8110002123593119,2.0370282673670057,"['NOTCH2', 'PDGFRB']",0.9881408020228055,0,0,2
95,Hippo-Yap signaling pathway WP4537,0.3247146738431905,1.8110002123593119,2.0370282673670057,"['TNIK', 'TEAD1']",0.9881408020228055,0,0,2
96,Adipogenesis WP236,0.3403335749014892,1.2537445802128497,1.35132231690377,"['NCOA1', 'GDF10', 'IRS1', 'ASIP', 'RORA', 'PLIN2', 'LPIN2']",0.9881408020228055,0,0,7
97,7-oxo-C and 7beta-HC pathways WP5064,0.34752314801512807,1.7102553817355262,1.8076099645628105,"['CYP27A1', 'ACOT11']",0.9881408020228055,0,0,2
98,Canonical and non-canonical Notch signaling WP3845,0.34752314801512807,1.7102553817355262,1.8076099645628105,"['NOTCH2', 'ADAM10']",0.9881408020228055,0,0,2
99,Striated Muscle Contraction Pathway WP383,0.34752314801512807,1.7102553817355262,1.8076099645628105,"['ACTN2', 'MYL3']",0.9881408020228055,0,0,2
100,Selenium Micronutrient Network WP15,0.3508164459711403,1.3686101058839297,1.4336083262447799,"['TXNRD1', 'GSR', 'MTR', 'SELENOI']",0.9881408020228055,0,0,4
101,"GPCRs, Class A Rhodopsin-like WP455",0.35246716191651417,1.3049619258167526,1.3608114497973036,"['OXTR', 'GPR37', 'GPR35', 'GPER1', 'ADORA1']",0.9881408020228055,0,0,5
102,Biogenic Amine Synthesis WP550,0.3566947063501786,2.5647035256410255,2.6438888171380013,['MAOA'],0.9881408020228055,0,0,1
103,"Cerebral organic acidurias, including diseases WP4519",0.3566947063501786,2.5647035256410255,2.6438888171380013,['L2HGDH'],0.9881408020228055,0,0,1
104,Estrogen metabolism WP697,0.3566947063501786,2.5647035256410255,2.6438888171380013,['SULT1A1'],0.9881408020228055,0,0,1
105,Nephrogenesis WP5052,0.3566947063501786,2.5647035256410255,2.6438888171380013,['NOTCH2'],0.9881408020228055,0,0,1
106,Fas ligand pathway and stress induction of heat shock proteins WP314,0.36151499105712415,1.4431852409638555,1.4683713767098634,"['DFFA', 'PRKDC', 'NFX1']",0.9881408020228055,0,0,3
107,Mechanoregulation and pathology of YAP/TAZ via Hippo and non-Hippo mechanisms WP4534,0.36151499105712415,1.4431852409638555,1.4683713767098634,"['CTNNA1', 'MAP4K5', 'TEAD1']",0.9881408020228055,0,0,3
108,Hippo-Merlin Signaling Dysregulation WP4541,0.36305434257045954,1.2485702147128992,1.2650547774512333,"['PDGFRB', 'DDB1', 'PPP1R12A', 'CTNNA1', 'ITGA7', 'TEAD1']",0.9881408020228055,0,0,6
109,Kit receptor signaling pathway WP304,0.3649594057437473,1.3387528190066607,1.3494215393275368,"['RPS6KA3', 'SHC1', 'INPP5D', 'MAPT']",0.9881408020228055,0,0,4
110,Retinoblastoma gene in cancer WP2446,0.37714155197218363,1.2619783004672527,1.230598822072416,"['POLD3', 'RFC3', 'PRKDC', 'HMGB2', 'HMGB1']",0.9881408020228055,0,0,5
111,p53 transcriptional gene network WP4963,0.37908744384585347,1.310166054975233,1.2708458465284456,"['MSH2', 'SESN1', 'FANCC', 'ISG15']",0.9881408020228055,0,0,4
112,TLR4 Signaling and Tolerance WP3851,0.39229474193571,1.5389891696750904,1.4400965404864141,"['TRAF3', 'INPP5D']",0.9881408020228055,0,0,2
113,Type II interferon signaling (IFNG) WP619,0.39229474193571,1.5389891696750904,1.4400965404864141,"['ISG15', 'GBP1']",0.9881408020228055,0,0,2
114,Arrhythmogenic Right Ventricular Cardiomyopathy WP2118,0.3931828672737772,1.2827704061117813,1.197441114168644,"['ACTN2', 'CTNNA1', 'ITGA7', 'CACNA1D']",0.9881408020228055,0,0,4
115,Heme Biosynthesis WP561,0.3959959476785821,2.1981456043956045,2.0362550402322572,['FECH'],0.9881408020228055,0,0,1
116,Insulin signaling in adipocytes (diabetic condition) WP3635,0.3959959476785821,2.1981456043956045,2.0362550402322572,['IRS1'],0.9881408020228055,0,0,1
117,Insulin signaling in adipocytes (normal condition) WP3634,0.3959959476785821,2.1981456043956045,2.0362550402322572,['IRS1'],0.9881408020228055,0,0,1
118,Leptin and adiponectin WP3934,0.3959959476785821,2.1981456043956045,2.0362550402322572,['LEPR'],0.9881408020228055,0,0,1
119,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.3959959476785821,2.1981456043956045,2.0362550402322572,['STAG1'],0.9881408020228055,0,0,1
120,Supression of HMGB1 mediated inflammation by THBD WP4479,0.3959959476785821,2.1981456043956045,2.0362550402322572,['HMGB1'],0.9881408020228055,0,0,1
121,Valproic acid pathway WP3871,0.3959959476785821,2.1981456043956045,2.0362550402322572,['IVD'],0.9881408020228055,0,0,1
122,Calcium Regulation in the Cardiac Cell WP536,0.4046021987597934,1.1511299915038233,1.0416010316899995,"['RGS5', 'PKIB', 'CACNA1A', 'ATP1B3', 'CACNA1D', 'ATP2B2', 'CALR', 'ADCY8']",0.9881408020228055,0,0,8
123,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.4120764672613946,1.3191738382099827,1.1695087469340992,"['TRAF3', 'DHX58', 'TRIM25']",0.9881408020228055,0,0,3
124,MAPK Signaling Pathway WP382,0.412884099877962,1.0999128919860628,0.9729701360297379,"['PDGFRB', 'DUSP1', 'CACNA1A', 'CACNA1D', 'HSPA2', 'RASGRP1', 'DUSP16', 'RPS6KA3', 'NR4A1', 'PPP3CB', 'MRAS', 'RAP1A', 'MAPT']",0.9881408020228055,0,0,13
125,Pre-implantation embryo WP3527,0.41415976632277696,1.465589364506332,1.2919221112989903,"['H2AFY2', 'KLF4']",0.9881408020228055,0,0,2
126,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.42120920463019357,1.2312665862484922,1.0645846670568906,"['FZD3', 'SHC1', 'FZD9', 'MYLK']",0.9881408020228055,0,0,4
127,Glycogen Synthesis and Degradation WP500,0.4286669978882286,1.282429718875502,1.0863140132728215,"['PYGB', 'PPP2R2C', 'PPP2R2B']",0.9881408020228055,0,0,3
128,Regulation of Microtubule Cytoskeleton WP2038,0.4286669978882286,1.282429718875502,1.0863140132728215,"['TESK2', 'MAPT', 'EPHB2']",0.9881408020228055,0,0,3
129,Cytosine methylation WP3585,0.4328988725820219,1.9232271634615385,1.6102241136926359,['TET3'],0.9881408020228055,0,0,1
130,Dopamine metabolism WP2436,0.4328988725820219,1.9232271634615385,1.6102241136926359,['MAOA'],0.9881408020228055,0,0,1
131,Serotonin and anxiety-related events WP3944,0.4328988725820219,1.9232271634615385,1.6102241136926359,['PLCD4'],0.9881408020228055,0,0,1
132,SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991,0.4328988725820219,1.9232271634615385,1.6102241136926359,['KLF4'],0.9881408020228055,0,0,1
133,Transcriptional cascade regulating adipogenesis WP4211,0.4328988725820219,1.9232271634615385,1.6102241136926359,['KLF2'],0.9881408020228055,0,0,1
134,Vitamin B12 Disorders WP4271,0.4328988725820219,1.9232271634615385,1.6102241136926359,['MTR'],0.9881408020228055,0,0,1
135,Gastric Cancer Network 2 WP2363,0.43562385843928214,1.39886226889837,1.1624211378023257,"['RFC3', 'DSCC1']",0.9881408020228055,0,0,2
136,TYROBP causal network in microglia WP3945,0.43562385843928214,1.39886226889837,1.1624211378023257,"['ADAP2', 'TMEM106A']",0.9881408020228055,0,0,2
137,Nuclear Receptors Meta-Pathway WP2882,0.4564077480223945,1.0643033212247015,0.8348061962469486,"['NCOA1', 'CBR1', 'TXNRD1', 'GSR', 'SLC39A11', 'SLC39A12', 'SLC5A3', 'PRDX6', 'SULT1A1', 'SLC6A9', 'CPT2', 'DNAJC7', 'FTH1']",0.9881408020228055,0,0,13
138,Vitamin B12 metabolism WP1533,0.4566544388320252,1.3379375294302307,1.0487133332724905,"['MCEE', 'MTR']",0.9881408020228055,0,0,2
139,H19 action Rb-E2F1 signaling and CDK-Beta-catenin activity WP3969,0.46754967025149247,1.7094017094017093,1.2995721185810276,['H2AFY'],0.9881408020228055,0,0,1
140,Major receptors targeted by epinephrine and norepinephrine WP4589,0.46754967025149247,1.7094017094017093,1.2995721185810276,['ADCY8'],0.9881408020228055,0,0,1
141,Non-homologous end joining WP438,0.46754967025149247,1.7094017094017093,1.2995721185810276,['PRKDC'],0.9881408020228055,0,0,1
142,Pathways of nucleic acid metabolism and innate immune sensing WP4705,0.46754967025149247,1.7094017094017093,1.2995721185810276,['RNASEH2C'],0.9881408020228055,0,0,1
143,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.47618399861705074,1.1397042398248671,0.8456046408655044,"['FZD3', 'KREMEN1', 'FZD9', 'KLF4']",0.9881408020228055,0,0,4
144,GABA receptor Signaling WP4159,0.47722439089441376,1.2820898515844363,0.9484496575823201,"['AP2A1', 'GPHN']",0.9881408020228055,0,0,2
145,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.47722439089441376,1.2820898515844363,0.9484496575823201,"['CYP11A1', 'PDK1']",0.9881408020228055,0,0,2
146,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.47722439089441376,1.2820898515844363,0.9484496575823201,"['RAP1A', 'TEAD1']",0.9881408020228055,0,0,2
147,Oxidation by Cytochrome P450 WP43,0.47722439089441376,1.2820898515844363,0.9484496575823201,"['CYP27A1', 'CYP11A1']",0.9881408020228055,0,0,2
148,Oxysterols derived from cholesterol WP4545,0.47722439089441376,1.2820898515844363,0.9484496575823201,"['CYP27A1', 'ACOT11']",0.9881408020228055,0,0,2
149,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.47722439089441376,1.2820898515844363,0.9484496575823201,"['CYP11A1', 'CREB5']",0.9881408020228055,0,0,2
150,Vitamin A and carotenoid metabolism WP716,0.47722439089441376,1.2820898515844363,0.9484496575823201,"['SULT1A1', 'ALDH1A1']",0.9881408020228055,0,0,2
151,Cytosolic DNA-sensing pathway WP4655,0.47733804690631704,1.1835032437442077,0.8752365625982015,"['IL33', 'TRIM25', 'ISG15']",0.9881408020228055,0,0,3
152,Proteasome Degradation WP183,0.48962544103271766,1.1188946156376796,0.7990189654927381,"['UBA7', 'UBE2D1', 'PSME2', 'HLA-E']",0.9881408020228055,0,0,4
153,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.4931333690767794,1.1538253012048192,0.8157263530920078,"['PPP1R13B', 'PPP1R12A', 'EIF2AK3']",0.9881408020228055,0,0,3
154,Energy Metabolism WP1541,0.4931333690767794,1.1538253012048192,0.8157263530920078,"['NCOA1', 'PPP3CB', 'NRF1']",0.9881408020228055,0,0,3
155,Exercise-induced Circadian Regulation WP410,0.4931333690767794,1.1538253012048192,0.8157263530920078,"['BTG1', 'CRY2', 'ERC2']",0.9881408020228055,0,0,3
156,One-carbon metabolism and related pathways WP3940,0.4931333690767794,1.1538253012048192,0.8157263530920078,"['CHDH', 'GSR', 'MTR']",0.9881408020228055,0,0,3
157,Wnt signaling in kidney disease WP4150,0.49731151663473727,1.2307099879663057,0.8596984999415511,"['FZD3', 'FZD9']",0.9881408020228055,0,0,2
158,Disorders of Folate Metabolism and Transport WP4259,0.5000856292270347,1.5383413461538462,1.0660335354213397,['MTR'],0.9881408020228055,0,0,1
159,Ganglio Sphingolipid Metabolism WP1423,0.5000856292270347,1.5383413461538462,1.0660335354213397,['ST8SIA1'],0.9881408020228055,0,0,1
160,Glutathione metabolism WP100,0.5000856292270347,1.5383413461538462,1.0660335354213397,['GSR'],0.9881408020228055,0,0,1
161,Mammalian disorder of sexual development WP4842,0.5000856292270347,1.5383413461538462,1.0660335354213397,['PTGDS'],0.9881408020228055,0,0,1
162,Matrix Metalloproteinases WP129,0.5000856292270347,1.5383413461538462,1.0660335354213397,['MMP16'],0.9881408020228055,0,0,1
163,Tryptophan catabolism leading to NAD+ production WP4210,0.5000856292270347,1.5383413461538462,1.0660335354213397,['NADSYN1'],0.9881408020228055,0,0,1
164,MECP2 and Associated Rett Syndrome WP3584,0.502922652270269,1.0988281923143202,0.7552453773201446,"['CSRP1', 'TET3', 'SP3', 'TAF1']",0.9881408020228055,0,0,4
165,Synaptic Vesicle Pathway WP2267,0.5086881175469588,1.1255950631795475,0.7608124243467663,"['RIMS1', 'CACNA1A', 'AP2A1']",0.9881408020228055,0,0,3
166,Vitamin D Receptor Pathway WP2877,0.5101461845484603,1.0682534889962427,0.7189965118944978,"['BGLAP', 'NFATC2', 'CD9', 'KLF4', 'RASGRP1']",0.9881408020228055,0,0,5
167,Wnt signaling pathway and pluripotency WP399,0.5101461845484603,1.0682534889962427,0.7189965118944978,"['FZD3', 'RACGAP1', 'PPP2R2C', 'PPP2R2B', 'FZD9']",0.9881408020228055,0,0,5
168,Circadian rhythm related genes WP3594,0.5121342231280028,1.0331383132879293,0.6913436502661539,"['SETX', 'KDM5A', 'AHCY', 'PRKDC', 'CRY2', 'ADORA1', 'DYRK1A', 'RORA', 'PTGDS']",0.9881408020228055,0,0,9
169,Trans-sulfuration and one-carbon metabolism WP2525,0.5168980383877735,1.1832824215495696,0.7808594788847604,"['AHCY', 'MTR']",0.9881408020228055,0,0,2
170,Genotoxicity pathway WP4286,0.5239889199339844,1.098709122203098,0.7100789394322842,"['SEL1L', 'PPM1D', 'TOPORS']",0.9881408020228055,0,0,3
171,PPAR signaling pathway WP3942,0.5239889199339844,1.098709122203098,0.7100789394322842,"['CYP27A1', 'CPT2', 'FABP5']",0.9881408020228055,0,0,3
172,Cancer immunotherapy by PD-1 blockade WP4585,0.5306356783370213,1.398382867132867,0.8861266931571141,['NFATC2'],0.9881408020228055,0,0,1
173,Cell Differentiation - Index expanded WP2023,0.5306356783370213,1.398382867132867,0.8861266931571141,['KLF4'],0.9881408020228055,0,0,1
174,Fatty acid transporters WP5061,0.5306356783370213,1.398382867132867,0.8861266931571141,['FABP5'],0.9881408020228055,0,0,1
175,FOXA2 pathway WP5066,0.5306356783370213,1.398382867132867,0.8861266931571141,['IRS1'],0.9881408020228055,0,0,1
176,Serotonin and anxiety WP3947,0.5306356783370213,1.398382867132867,0.8861266931571141,['PLCD4'],0.9881408020228055,0,0,1
177,Androgen receptor signaling pathway WP138,0.5332036409773602,1.0392185663924793,0.6535145306684164,"['NCOA1', 'ZMIZ1', 'CALR', 'PLPP1', 'PIAS1']",0.9881408020228055,0,0,5
178,Alpha 6 Beta 4 signaling pathway WP244,0.5359701428125525,1.1393680082007398,0.7105974197770437,"['SHC1', 'IRS1']",0.9881408020228055,0,0,2
179,Base Excision Repair WP4752,0.5359701428125525,1.1393680082007398,0.7105974197770437,"['POLD3', 'HMGB1']",0.9881408020228055,0,0,2
180,PDGFR-beta pathway WP3972,0.5359701428125525,1.1393680082007398,0.7105974197770437,"['PDGFRB', 'SHC1']",0.9881408020228055,0,0,2
181,Proximal tubule transport WP4917,0.5359701428125525,1.1393680082007398,0.7105974197770437,"['SLC13A3', 'SLC47A1']",0.9881408020228055,0,0,2
182,IL-4 signaling pathway WP395,0.5390239400716457,1.0730736901092743,0.6631544898968241,"['IRS1', 'SHC1', 'INPP5D']",0.9881408020228055,0,0,3
183,Angiopoietin Like Protein 8 Regulatory Pathway WP3915,0.5495970298930121,1.0060193252019642,0.6021729293516993,"['RPS6KA3', 'THRB', 'IRS1', 'SHC1', 'TRIP10', 'MAP4K5', 'RHOQ']",0.9881408020228055,0,0,7
184,Copper homeostasis WP3286,0.5537828010880785,1.048603504928806,0.6197065566893458,"['BACE1', 'ADAM10', 'MAPT']",0.9881408020228055,0,0,3
185,Interferon type I signaling pathways WP585,0.5537828010880785,1.048603504928806,0.6197065566893458,"['RAP1A', 'IRS1', 'PIAS1']",0.9881408020228055,0,0,3
186,Neural Crest Differentiation WP2064,0.5544758373068657,1.0252513067953357,0.6046235536733708,"['NOTCH2', 'PRTG', 'FZD3', 'DCT']",0.9881408020228055,0,0,4
187,Hedgehog Signaling Pathway Netpath WP47,0.5593208952906638,1.2817508012820513,0.7447381266383952,['GLI1'],0.9881408020228055,0,0,1
188,Omega-3/Omega-6 FA synthesis WP4723,0.5593208952906638,1.2817508012820513,0.7447381266383952,['PLA2G5'],0.9881408020228055,0,0,1
189,Omega-9 FA synthesis WP4724,0.5593208952906638,1.2817508012820513,0.7447381266383952,['ELOVL6'],0.9881408020228055,0,0,1
190,PPAR-alpha pathway WP2878,0.5593208952906638,1.2817508012820513,0.7447381266383952,['CPT2'],0.9881408020228055,0,0,1
191,Riboflavin and CoQ disorders WP5037,0.5593208952906638,1.2817508012820513,0.7447381266383952,['APTX'],0.9881408020228055,0,0,1
192,Endoderm differentiation WP2853,0.5673897352368598,0.9920037445879003,0.5621772989571168,"['EPB41L5', 'SESN1', 'UBR5', 'LRPPRC', 'PIAS1', 'PARP8']",0.9881408020228055,0,0,6
193,Rett syndrome causing genes WP4312,0.568256508203776,1.0252208835341365,0.5794367618098885,"['CDKL5', 'KCNJ10', 'RHOBTB2']",0.9881408020228055,0,0,3
194,Initiation of transcription and translation elongation at the HIV-1 LTR WP3414,0.5725332030766863,1.0606249221959418,0.5914941309634322,"['PPP3CB', 'NFATC2']",0.9881408020228055,0,0,2
195,DNA IR-damage and cellular response via ATR WP4016,0.5791568889262215,0.9920230359157944,0.541824999600718,"['MSH2', 'PRKDC', 'TDP1', 'PPM1D']",0.9881408020228055,0,0,4
196,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.5791568889262215,0.9920230359157944,0.541824999600718,"['FZD3', 'H2AFY2', 'KREMEN1', 'FZD9']",0.9881408020228055,0,0,4
197,Translation Factors WP107,0.582437372557908,1.0028548978522787,0.5420767824988624,"['EIF2AK3', 'EIF4EBP2', 'EIF3E']",0.9881408020228055,0,0,3
198,Airway smooth muscle cell contraction WP4962,0.5862549844305824,1.1830621301775148,0.6317557182106074,['MYLK'],0.9881408020228055,0,0,1
199,Cori Cycle WP1946,0.5862549844305824,1.1830621301775148,0.6317557182106074,['PFKP'],0.9881408020228055,0,0,1
200,Imatinib and Chronic Myeloid Leukemia WP3640,0.5862549844305824,1.1830621301775148,0.6317557182106074,['PDGFRB'],0.9881408020228055,0,0,1
201,Phytochemical activity on NRF2 transcriptional activation WP3,0.5862549844305824,1.1830621301775148,0.6317557182106074,['EPHB2'],0.9881408020228055,0,0,1
202,Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664,0.5862549844305824,1.1830621301775148,0.6317557182106074,['DKK3'],0.9881408020228055,0,0,1
203,SARS coronavirus and innate immunity WP4912,0.5862549844305824,1.1830621301775148,0.6317557182106074,['TRAF3'],0.9881408020228055,0,0,1
204,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.5862549844305824,1.1830621301775148,0.6317557182106074,['NRF1'],0.9881408020228055,0,0,1
205,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.5900127798219066,1.0251905334937825,0.5409018862246485,"['IRS1', 'PDK1']",0.9881408020228055,0,0,2
206,IL-5 signaling pathway WP127,0.5900127798219066,1.0251905334937825,0.5409018862246485,"['SHC1', 'MAPT']",0.9881408020228055,0,0,2
207,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.5900127798219066,1.0251905334937825,0.5409018862246485,"['SHC1', 'AP2A1']",0.9881408020228055,0,0,2
208,p38 MAPK Signaling Pathway WP400,0.5900127798219066,1.0251905334937825,0.5409018862246485,"['SHC1', 'HMGN1']",0.9881408020228055,0,0,2
209,Leptin signaling pathway WP2034,0.5912000272198408,0.9762000497826795,0.5130915889255923,"['NCOA1', 'IRS1', 'SHC1', 'LEPR']",0.9881408020228055,0,0,4
210,Allograft Rejection WP2328,0.6069545163267345,0.9920422343853111,0.49532809895409047,"['COL5A1', 'HLA-E']",0.9881408020228055,0,0,2
211,Parkinson's disease pathway WP2371,0.6069545163267345,0.9920422343853111,0.49532809895409047,"['GPR37', 'UBA7']",0.9881408020228055,0,0,2
212,Wnt signaling WP428,0.6096499144258835,0.9488876960696606,0.4695764311867836,"['FZD3', 'PPP3CB', 'FZD9', 'KREMEN1', 'NFATC2']",0.9881408020228055,0,0,5
213,TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453,0.6115447247964889,1.0984718406593406,0.5401924071260719,['ACO1'],0.9881408020228055,0,0,1
214,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.6146655220681742,0.9460146608518141,0.46040360139350245,"['THRB', 'TTF2', 'ADCY8', 'MAP4K5']",0.9881408020228055,0,0,4
215,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.6233588476613555,0.9609657039711191,0.4541840329938402,"['BST2', 'RPS6KA3']",0.9881408020228055,0,0,2
216,IL-2 signaling pathway WP49,0.6233588476613555,0.9609657039711191,0.4541840329938402,"['SHC1', 'MAPT']",0.9881408020228055,0,0,2
217,Corticotropin-releasing hormone signaling pathway WP2355,0.626079345713531,0.9316079979529919,0.4362516843146372,"['NR4A2', 'NR4A1', 'GRK3', 'CYP11A1']",0.9881408020228055,0,0,4
218,Interactome of polycomb repressive complex 2 (PRC2)  WP2916,0.6352903918884137,1.0251602564102564,0.4650876054457712,['SETX'],0.9881408020228055,0,0,1
219,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.6352903918884137,1.0251602564102564,0.4650876054457712,['EIF3E'],0.9881408020228055,0,0,1
220,Serotonin Receptor 4/6/7 and NR3C Signaling WP734,0.6352903918884137,1.0251602564102564,0.4650876054457712,['RAP1A'],0.9881408020228055,0,0,1
221,Transcription co-factors SKI and SKIL protein partners WP4533,0.6352903918884137,1.0251602564102564,0.4650876054457712,['TEAD1'],0.9881408020228055,0,0,1
222,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.6361201315740833,0.9223373493975904,0.41723576128300843,"['SCARB2', 'PLCE1', 'TLN1']",0.9881408020228055,0,0,3
223,Nephrotic syndrome WP4758,0.6392281590228686,0.9317725996426357,0.41696249112964084,"['SCARB2', 'PLCE1']",0.9881408020228055,0,0,2
224,7q11.23 copy number variation syndrome WP4932,0.6400992962921508,0.914783183804923,0.40811401861398544,"['CLIP2', 'FZD9', 'EIF2AK3', 'HSPA2', 'DEK']",0.9881408020228055,0,0,5
225,Metapathway biotransformation Phase I and II WP702,0.6499149727606213,0.903949985791418,0.38952446534151824,"['CYP27A1', 'SULT1A1', 'CYP11A1', 'GSR', 'NAT10']",0.9881408020228055,0,0,5
226,IL-6 signaling pathway WP364,0.6545665464657586,0.9042967367452396,0.3832247009680302,"['NCOA1', 'SHC1']",0.9881408020228055,0,0,2
227,PDGF Pathway WP2526,0.6545665464657586,0.9042967367452396,0.3832247009680302,"['PDGFRB', 'SHC1']",0.9881408020228055,0,0,2
228,Globo Sphingolipid Metabolism WP1424,0.6575861530199608,0.9610126201923077,0.4028367822309003,['ST8SIA1'],0.9881408020228055,0,0,1
229,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.6575861530199608,0.9610126201923077,0.4028367822309003,['SHC1'],0.9881408020228055,0,0,1
230,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.6575861530199608,0.9610126201923077,0.4028367822309003,['CPT2'],0.9881408020228055,0,0,1
231,Transcription factor regulation in adipogenesis WP3599,0.6575861530199608,0.9610126201923077,0.4028367822309003,['IRS1'],0.9881408020228055,0,0,1
232,3q29 copy number variation syndrome WP4906,0.6610880681959542,0.8867238183503243,0.3669868023165171,"['ADAM10', 'FGFR1OP', 'PIGM']",0.9881408020228055,0,0,3
233,Cell cycle WP179,0.6690312126690804,0.8830307068687878,0.3549117320631359,"['STAG1', 'PRKDC', 'ORC3', 'CDC27', 'MCM5']",0.9881408020228055,0,0,5
234,Folate Metabolism WP176,0.6693795994693509,0.8783909231562661,0.3525896007050987,"['AHCY', 'MTR']",0.9881408020228055,0,0,2
235,Pathways in clear cell renal cell carcinoma WP4018,0.6695356153788065,0.8780975357573669,0.3522671947633843,"['PDGFRB', 'PLOD2', 'SDSL', 'PFKP']",0.9881408020228055,0,0,4
236,Integrated breast cancer pathway WP1984,0.6720333719559278,0.8886398655273848,0.35318749660329385,"['RAP1A', 'MSH2', 'RASGEF1A', 'IRS1', 'ZMIZ1', 'ODC1', 'PIAS1']",0.9881408020228055,0,0,7
237,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.6785204391663896,0.9044117647058824,0.3507676703082583,['ZFX'],0.9881408020228055,0,0,1
238,NAD+ biosynthetic pathways WP3645,0.6785204391663896,0.9044117647058824,0.3507676703082583,['NADSYN1'],0.9881408020228055,0,0,1
239,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.6785204391663896,0.9044117647058824,0.3507676703082583,['NQO2'],0.9881408020228055,0,0,1
240,Purinergic signaling WP4900,0.6785204391663896,0.9044117647058824,0.3507676703082583,['ADORA1'],0.9881408020228055,0,0,1
241,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.6785204391663896,0.9044117647058824,0.3507676703082583,['RASGRP1'],0.9881408020228055,0,0,1
242,Urea cycle and associated pathways WP4595,0.6785204391663896,0.9044117647058824,0.3507676703082583,['GLUD1'],0.9881408020228055,0,0,1
243,Common Pathways Underlying Drug Addiction WP2636,0.6836742037884864,0.8539243214333467,0.32472503388512103,"['RAP1A', 'ADCY8']",0.9881408020228055,0,0,2
244,IL-3 signaling pathway WP286,0.6836742037884864,0.8539243214333467,0.32472503388512103,"['SHC1', 'INPP5D']",0.9881408020228055,0,0,2
245,Notch Signaling WP268,0.6836742037884864,0.8539243214333467,0.32472503388512103,"['NOTCH2', 'DTX4']",0.9881408020228055,0,0,2
246,Complement system WP2806,0.6974583627038381,0.830780238722477,0.2993404732919933,"['CD59', 'CALR']",0.9881408020228055,0,0,2
247,Netrin-UNC5B signaling pathway WP4747,0.6974583627038381,0.830780238722477,0.2993404732919933,"['INPP5D', 'RLF']",0.9881408020228055,0,0,2
248,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.6974583627038381,0.830780238722477,0.2993404732919933,"['NFATC2', 'PDK1']",0.9881408020228055,0,0,2
249,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.6981762938633546,0.8540998931623932,0.30686411692081184,['PDK1'],0.9881408020228055,0,0,1
250,Mitochondrial Gene Expression WP391,0.6981762938633546,0.8540998931623932,0.30686411692081184,['NRF1'],0.9881408020228055,0,0,1
251,Peptide GPCRs WP24,0.6981762938633546,0.8540998931623932,0.30686411692081184,['OXTR'],0.9881408020228055,0,0,1
252,Type I interferon induction and signaling during SARS-CoV-2 infection WP4868,0.6981762938633546,0.8540998931623932,0.30686411692081184,['TRAF3'],0.9881408020228055,0,0,1
253,Vitamin D in inflammatory diseases WP4482,0.6981762938633546,0.8540998931623932,0.30686411692081184,['DUSP1'],0.9881408020228055,0,0,1
254,Endochondral Ossification with Skeletal Dysplasias WP4808,0.7107410351824286,0.8088542656279688,0.2761809770589466,"['SERPINH1', 'SLC38A2']",0.9881408020228055,0,0,2
255,Endochondral Ossification WP474,0.7107410351824286,0.8088542656279688,0.2761809770589466,"['SERPINH1', 'SLC38A2']",0.9881408020228055,0,0,2
256,Interleukin-11 Signaling Pathway WP2332,0.7107410351824286,0.8088542656279688,0.2761809770589466,"['BGLAP', 'PIAS1']",0.9881408020228055,0,0,2
257,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.7166317012049941,0.809084008097166,0.2695813194484608,['GLI1'],0.9881408020228055,0,0,1
258,Immune response to tuberculosis WP4197,0.7166317012049941,0.809084008097166,0.2695813194484608,['PIAS1'],0.9881408020228055,0,0,1
259,Signal Transduction of S1P Receptor WP26,0.7166317012049941,0.809084008097166,0.2695813194484608,['RACGAP1'],0.9881408020228055,0,0,1
260,Fragile X Syndrome  WP4549,0.7190686498448259,0.8375728262064417,0.2762302166636483,"['CYFIP2', 'SHC1', 'EIF4EBP2', 'AP2A1', 'GPHN', 'PDK1']",0.9881408020228055,0,0,6
261,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.7235319895807216,0.7880527014101021,0.2550221435837166,"['CYP27A1', 'TM7SF2']",0.9881408020228055,0,0,2
262,Histone Modifications WP2369,0.7235319895807216,0.7880527014101021,0.2550221435837166,"['SETBP1', 'SMYD5']",0.9881408020228055,0,0,2
263,Differentiation Pathway WP2848,0.7339598934717424,0.7685697115384615,0.2377192980402525,['ALK'],0.9881408020228055,0,0,1
264,SARS-CoV-2 mitochondrial interactions WP5038,0.7339598934717424,0.7685697115384615,0.2377192980402525,['TRAF3'],0.9881408020228055,0,0,1
265,Sphingolipid Metabolism (general overview) WP4725,0.7339598934717424,0.7685697115384615,0.2377192980402525,['DEGS2'],0.9881408020228055,0,0,1
266,Unfolded protein response WP4925,0.7339598934717424,0.7685697115384615,0.2377192980402525,['EIF2AK3'],0.9881408020228055,0,0,1
267,Eukaryotic Transcription Initiation WP405,0.7358416717173752,0.7682912154031287,0.23566588046935863,"['POLR1A', 'GTF2H3']",0.9881408020228055,0,0,2
268,Phosphodiesterases in neuronal function WP4222,0.7358416717173752,0.7682912154031287,0.23566588046935863,"['ADCY8', 'PDE7A']",0.9881408020228055,0,0,2
269,22q11.2 copy number variation syndrome WP4657,0.7369034514029882,0.7978318424639294,0.24357678301161476,"['GLUD1', 'XPO1', 'SNAP29', 'DGCR2']",0.9881408020228055,0,0,4
270,Osteoblast differentiation WP4787,0.7369034514029882,0.7978318424639294,0.24357678301161476,"['NOTCH2', 'FZD3', 'PRKDC', 'FZD9']",0.9881408020228055,0,0,4
271,Genes related to primary cilium development (based on CRISPR) WP4536,0.7384471801941046,0.8081617086193745,0.24503923872801428,"['ARMC9', 'CEP83', 'FGFR1OP', 'TUBD1', 'WDR35']",0.9881408020228055,0,0,5
272,Head and Neck Squamous Cell Carcinoma WP4674,0.7385711893171385,0.7810904635491117,0.2366999235500411,"['NOTCH2', 'TRAF3', 'SESN1']",0.9881408020228055,0,0,3
273,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.7502296406642485,0.7319139194139194,0.2103344445635619,['MTA2'],0.9881408020228055,0,0,1
274,Estrogen signaling pathway WP712,0.7502296406642485,0.7319139194139194,0.2103344445635619,['GPER1'],0.9881408020228055,0,0,1
275,Fluoropyrimidine Activity WP1601,0.7502296406642485,0.7319139194139194,0.2103344445635619,['UPP2'],0.9881408020228055,0,0,1
276,Heart Development WP1591,0.7502296406642485,0.7319139194139194,0.2103344445635619,['NFATC2'],0.9881408020228055,0,0,1
277,NRF2-ARE regulation WP4357,0.7502296406642485,0.7319139194139194,0.2103344445635619,['EPHB2'],0.9881408020228055,0,0,1
278,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.7502296406642485,0.7319139194139194,0.2103344445635619,['ERBIN'],0.9881408020228055,0,0,1
279,Sphingolipid Metabolism (integrated pathway) WP4726,0.7502296406642485,0.7319139194139194,0.2103344445635619,['DEGS2'],0.9881408020228055,0,0,1
280,Toll-like Receptor Signaling related to MyD88 WP3858,0.7502296406642485,0.7319139194139194,0.2103344445635619,['TRAF3'],0.9881408020228055,0,0,1
281,Male infertility WP4673,0.7624033699320116,0.7677322074788903,0.20827001436077894,"['PIWIL2', 'MTR', 'MLH3', 'PUM2']",0.9881408020228055,0,0,4
282,Endothelin Pathways WP2197,0.7655055219901206,0.698590472027972,0.18667654279199764,['MYLK'],0.9881408020228055,0,0,1
283,miRNAs involvement in the immune response in sepsis WP4329,0.7655055219901206,0.698590472027972,0.18667654279199764,['TRAF3'],0.9881408020228055,0,0,1
284,Physiological and pathological hypertrophy of the heart WP1528,0.7655055219901206,0.698590472027972,0.18667654279199764,['PPP3CB'],0.9881408020228055,0,0,1
285,Wnt Signaling Pathway WP363,0.7699952898106432,0.7145215906864802,0.18675513785285042,"['NFATC2', 'CSNK1G1']",0.9881408020228055,0,0,2
286,Ras signaling WP4223,0.7714650865988298,0.7956057752667922,0.20643094717996405,"['PDGFRB', 'RAP1A', 'MRAS', 'SHC1', 'PLCE1', 'PLA2G5', 'RASGRP1']",0.9881408020228055,0,0,7
287,16p11.2 proximal deletion syndrome WP4949,0.7761421174858644,0.7312679288582903,0.18531765123614438,"['PPP4R1', 'PPP4R2', 'PPP4R4']",0.9881408020228055,0,0,3
288,EGF/EGFR signaling pathway WP437,0.7776304996073724,0.7896934197407777,0.19861089894722198,"['RPS6KA3', 'RAP1A', 'SHC1', 'INPP5D', 'PLCE1', 'AP2A1', 'IQGAP1']",0.9881408020228055,0,0,7
289,DNA damage response (only ATM dependent) WP710,0.7783085595992875,0.7488893465532966,0.18769580489976104,"['IRS1', 'SHC1', 'HMGB1', 'PDK1']",0.9881408020228055,0,0,4
290,16p11.2 distal deletion syndrome WP4950,0.7798481806950169,0.6681647157190636,0.16614317783133228,['NFATC2'],0.9881408020228055,0,0,1
291,Aryl Hydrocarbon Receptor Pathway WP2873,0.7798481806950169,0.6681647157190636,0.16614317783133228,['NCOA1'],0.9881408020228055,0,0,1
292,Glycerophospholipid Biosynthetic Pathway WP2533,0.7798481806950169,0.6681647157190636,0.16614317783133228,['LPIN2'],0.9881408020228055,0,0,1
293,MTHFR deficiency WP4288,0.7798481806950169,0.6681647157190636,0.16614317783133228,['CHDH'],0.9881408020228055,0,0,1
294,Sphingolipid pathway WP1422,0.7798481806950169,0.6681647157190636,0.16614317783133228,['PLPP1'],0.9881408020228055,0,0,1
295,Tryptophan metabolism WP465,0.7798481806950169,0.6681647157190636,0.16614317783133228,['ALDH1A1'],0.9881408020228055,0,0,1
296,G1 to S cell cycle control WP45,0.7804939719010339,0.6982277650147686,0.17304057378929777,"['ORC3', 'MCM5']",0.9881408020228055,0,0,2
297,mRNA Processing WP411,0.7826513313292742,0.7736782742117403,0.18960377229219968,"['SF3B3', 'SNRPD1', 'SNRPF', 'SREK1', 'CLK3', 'PTBP2']",0.9881408020228055,0,0,6
298,Apoptosis Modulation and Signaling WP1772,0.784811265464972,0.7197853915662651,0.17441264950923568,"['DFFA', 'AIFM2', 'TRAF3']",0.9881408020228055,0,0,3
299,DNA IR-double strand breaks and cellular response via ATM WP3959,0.7905700082213096,0.6826581093729108,0.16042538225852532,"['PRKDC', 'HSF1']",0.9881408020228055,0,0,2
300,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.7965785922331913,0.7449228460203555,0.16941741738653268,"['NOTCH2', 'FZD3', 'SHC1', 'PDCD6', 'FZD9']",0.9881408020228055,0,0,5
301,Nanoparticle-mediated activation of receptor signaling WP2643,0.8059581486661609,0.6146153846153846,0.13258695890908326,['TLN1'],0.9881408020228055,0,0,1
302,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.8094088420549548,0.7306188175753393,0.15449016901614876,"['THRB', 'MAOA', 'DEAF1', 'SP3', 'RORA']",0.9881408020228055,0,0,5
303,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.8095037988258089,0.6535064137030494,0.1381080022737356,"['MAOA', 'HMGA2']",0.9881408020228055,0,0,2
304,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8129416939113066,0.7421890236767172,0.15370429582200776,"['RPS6KA3', 'CDKL5', 'RAP1A', 'IRS1', 'SHC1', 'MAPT']",0.9881408020228055,0,0,6
305,B Cell Receptor Signaling Pathway WP23,0.8167456515671366,0.6772324592487597,0.13709050925584998,"['SHC1', 'INPP5D', 'NFATC2']",0.9881408020228055,0,0,3
306,Joubert Syndrome WP4656,0.8167456515671366,0.6772324592487597,0.13709050925584998,"['NEK8', 'ARMC9', 'CEP41']",0.9881408020228055,0,0,3
307,IL17 signaling pathway WP2112,0.8178291503448637,0.5909301035502958,0.11883712336658818,['TRAF3'],0.9881408020228055,0,0,1
308,Intraflagellar transport proteins binding to dynein WP4532,0.8178291503448637,0.5909301035502958,0.11883712336658818,['WDR35'],0.9881408020228055,0,0,1
309,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.8178291503448637,0.5909301035502958,0.11883712336658818,['PDK1'],0.9881408020228055,0,0,1
310,DNA damage response WP707,0.8183864855039105,0.6398415563578018,0.12823741442245645,"['PRKDC', 'SESN1']",0.9881408020228055,0,0,2
311,Thermogenesis WP4321,0.8209918482866457,0.6974997258471324,0.13757630968806606,"['RPS6KA3', 'CPT2', 'ADCY8', 'CREB5']",0.9881408020228055,0,0,4
312,BDNF-TrkB Signaling WP3676,0.8289747244369134,0.5689992877492878,0.10672470050556435,['SHC1'],0.9881408020228055,0,0,1
313,Host-pathogen interaction of human coronaviruses - interferon induction WP4880,0.8289747244369134,0.5689992877492878,0.10672470050556435,['TRAF3'],0.9881408020228055,0,0,1
314,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.8311456604464935,0.6577796901893287,0.12165649588479477,"['PDGFRB', 'MRAS', 'SHC1']",0.9881408020228055,0,0,3
315,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.8325487641793887,0.7660388821385177,0.1403869538472985,"['PDGFRB', 'COL5A1', 'PPP2R2C', 'CAB39L', 'IRS1', 'PPP2R2B', 'COL11A1', 'COL5A2', 'ITGA7', 'CREB5']",0.9881408020228055,0,0,10
316,Breast cancer pathway WP4262,0.8331293995923746,0.7035855161104463,0.1284510094982403,"['NOTCH2', 'NCOA1', 'FZD3', 'SHC1', 'FZD9']",0.9881408020228055,0,0,5
317,miRNA regulation of DNA damage response WP1530,0.8350455638291795,0.6141516245487365,0.11071249193418167,"['PRKDC', 'SESN1']",0.9881408020228055,0,0,2
318,Notch Signaling Pathway Netpath WP61,0.8350455638291795,0.6141516245487365,0.11071249193418167,"['NOTCH2', 'MAPT']",0.9881408020228055,0,0,2
319,Development of ureteric collection system WP5053,0.8394391510490278,0.5486349587912088,0.09602279683491989,['GLI1'],0.9881408020228055,0,0,1
320,Neovascularisation processes WP4331,0.8394391510490278,0.5486349587912088,0.09602279683491989,['EPHB2'],0.9881408020228055,0,0,1
321,AGE/RAGE pathway WP2324,0.8428465449919117,0.6020622448738822,0.10293480594982221,"['IRS1', 'SHC1']",0.9881408020228055,0,0,2
322,Spinal Cord Injury WP2431,0.8445631729434522,0.6394076305220884,0.10801880147251265,"['NR4A1', 'VCAN', 'PLA2G5']",0.9881408020228055,0,0,3
323,ATM Signaling Pathway WP2516,0.8492640105768606,0.5296750663129973,0.08654105313214416,['AP3B2'],0.9881408020228055,0,0,1
324,Fatty acid beta-oxidation WP143,0.8492640105768606,0.5296750663129973,0.08654105313214416,['CPT2'],0.9881408020228055,0,0,1
325,"GPCRs, Other WP117",0.8492640105768606,0.5296750663129973,0.08654105313214416,['GPR143'],0.9881408020228055,0,0,1
326,miRNA regulation of prostate cancer signaling pathways WP3981,0.8492640105768606,0.5296750663129973,0.08654105313214416,['PDGFRB'],0.9881408020228055,0,0,1
327,Neural Crest Cell Migration during Development WP4564,0.8492640105768606,0.5296750663129973,0.08654105313214416,['EPHB2'],0.9881408020228055,0,0,1
328,Myometrial relaxation and contraction pathways WP289,0.8492940035669388,0.6845777260179434,0.11182567478867085,"['RGS5', 'PKIB', 'OXTR', 'ADCY8', 'PLCD1']",0.9881408020228055,0,0,5
329,MET in type 1 papillary renal cell carcinoma WP4205,0.8574518051318394,0.5792520945439684,0.08908335655213674,"['ALK', 'RAP1A']",0.9881408020228055,0,0,2
330,Oxidative Damage WP3941,0.858488348077696,0.5119791666666667,0.07811889283684595,['TRAF3'],0.9881408020228055,0,0,1
331,The influence of laminopathies on Wnt signaling WP4844,0.858488348077696,0.5119791666666667,0.07811889283684595,['HMGA2'],0.9881408020228055,0,0,1
332,Tumor suppressor activity of SMARCB1 WP4204,0.858488348077696,0.5119791666666667,0.07811889283684595,['GLI1'],0.9881408020228055,0,0,1
333,Type 2 papillary renal cell carcinoma WP4241,0.858488348077696,0.5119791666666667,0.07811889283684595,['COL21A1'],0.9881408020228055,0,0,1
334,Oncostatin M Signaling Pathway WP2374,0.8642797097398656,0.5684806346659536,0.08291791709218978,"['IRS1', 'SHC1']",0.9881408020228055,0,0,2
335,Amyotrophic lateral sclerosis (ALS) WP2447,0.8671488275347242,0.49542493796526055,0.0706201787813946,['PPP3CB'],0.9881408020228055,0,0,1
336,CAMKK2  Pathway WP4874,0.8671488275347242,0.49542493796526055,0.0706201787813946,['NFATC2'],0.9881408020228055,0,0,1
337,NO/cGMP/PKG mediated Neuroprotection WP4008,0.8671488275347242,0.49542493796526055,0.0706201787813946,['ACTN2'],0.9881408020228055,0,0,1
338,Signaling of Hepatocyte Growth Factor Receptor WP313,0.8671488275347242,0.49542493796526055,0.0706201787813946,['RAP1A'],0.9881408020228055,0,0,1
339,Hepatitis B infection WP4666,0.8688068449113087,0.660763368315842,0.09292609371074992,"['DDB1', 'TRAF3', 'NFATC2', 'HSPG2', 'CREB5']",0.9881408020228055,0,0,5
340,AMP-activated protein kinase (AMPK) signaling WP1403,0.8708065287528477,0.5581008642380484,0.0772051354445536,"['LEPR', 'SLC2A4RG']",0.9881408020228055,0,0,2
341,Aryl Hydrocarbon Receptor Netpath WP2586,0.8752798770765333,0.4799053485576923,0.06392895177268265,['PLAGL1'],0.9881408020228055,0,0,1
342,Disruption of postsynaptic signaling by CNV WP4875,0.8752798770765333,0.4799053485576923,0.06392895177268265,['DLGAP1'],0.9881408020228055,0,0,1
343,Glycolysis and Gluconeogenesis WP534,0.8752798770765333,0.4799053485576923,0.06392895177268265,['PFKP'],0.9881408020228055,0,0,1
344,Neural Crest Cell Migration in Cancer WP4565,0.8752798770765333,0.4799053485576923,0.06392895177268265,['EPHB2'],0.9881408020228055,0,0,1
345,Insulin Signaling WP481,0.8762475101705235,0.6710738841472563,0.08865334427700772,"['RPS6KA3', 'IRS1', 'SHC1', 'MAP4K5', 'SGK2', 'RHOQ']",0.9881408020228055,0,0,6
346,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.8770435194543893,0.5480917998968541,0.07190891230472886,"['GPR37', 'HSPA2']",0.9881408020228055,0,0,2
347,Target Of Rapamycin (TOR) Signaling WP1471,0.8829138249467021,0.46532634032634035,0.0579460080367782,['RRAGD'],0.9881408020228055,0,0,1
348,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.8829138249467021,0.46532634032634035,0.0579460080367782,['TRAF3'],0.9881408020228055,0,0,1
349,Apoptosis WP254,0.8830016888563104,0.5384339307957017,0.06699634638402337,"['DFFA', 'TRAF3']",0.9881408020228055,0,0,2
350,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.8830016888563104,0.5384339307957017,0.06699634638402337,"['RAP1A', 'TTF2']",0.9881408020228055,0,0,2
351,Regulation of toll-like receptor signaling pathway WP1449,0.8893705930972438,0.5751054216867469,0.06742608726544257,"['RNF31', 'TRAF3', 'SFTPD']",0.9881408020228055,0,0,3
352,Ferroptosis WP4313,0.8900810277762676,0.4516049208144796,0.05258613151770402,['FTH1'],0.9881408020228055,0,0,1
353,G13 Signaling Pathway WP524,0.8900810277762676,0.4516049208144796,0.05258613151770402,['IQGAP1'],0.9881408020228055,0,0,1
354,Integrated Cancer Pathway WP1971,0.8900810277762676,0.4516049208144796,0.05258613151770402,['MSH2'],0.9881408020228055,0,0,1
355,T-cell receptor (TCR) signaling pathway WP69,0.89412427411045,0.520100348773175,0.05820469236846808,"['SHC1', 'NFATC2']",0.9898333513391744,0,0,2
356,Electron Transport Chain (OXPHOS system in mitochondria) WP111,0.9029430424660922,0.5541878356800697,0.05658025234615063,"['UQCRC2', 'UQCR10', 'ATP5ME']",0.9907322950659154,0,0,3
357,ESC Pluripotency Pathways WP3931,0.9029430424660922,0.5541878356800697,0.05658025234615063,"['PDGFRB', 'FZD3', 'FZD9']",0.9907322950659154,0,0,3
358,Prolactin Signaling Pathway WP2037,0.9042569557639073,0.5029689688504863,0.050619660058355505,"['IRS1', 'SHC1']",0.9907322950659154,0,0,2
359,Nonalcoholic fatty liver disease WP4396,0.9050200863324775,0.6127536231884058,0.061151672292810405,"['IRS1', 'LEPR', 'EIF2AK3', 'UQCRC2', 'UQCR10']",0.9907322950659154,0,0,5
360,Non-small cell lung cancer WP4255,0.9134778899510687,0.4869252955895555,0.04406484371058702,"['ALK', 'PDK1']",0.9921740875941403,0,0,2
361,Metabolic reprogramming in colon cancer WP4290,0.914627031732329,0.4039410425101215,0.036047259306322334,['GLUD1'],0.9921740875941403,0,0,1
362,Splicing factor NOVA regulated synaptic proteins WP4148,0.914627031732329,0.4039410425101215,0.036047259306322334,['GPHN'],0.9921740875941403,0,0,1
363,Gastrin signaling pathway WP4659,0.9289425127581588,0.5108032128514056,0.03765049921109885,"['IRS1', 'SHC1', 'KLF4']",0.9921740875941403,0,0,3
364,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.9293707184090416,0.37429643527204504,0.02741630387009738,['ADCY8'],0.9921740875941403,0,0,1
365,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.9293707184090416,0.37429643527204504,0.02741630387009738,['PDK1'],0.9921740875941403,0,0,1
366,Glioblastoma signaling pathways WP2261,0.9330126684439494,0.45094499893820345,0.03126694793909111,"['PDGFRB', 'IRS1']",0.9921740875941403,0,0,2
367,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.9330126684439494,0.45094499893820345,0.03126694793909111,"['PPP3CB', 'MYLK']",0.9921740875941403,0,0,2
368,Ebola Virus Pathway on Host WP4217,0.9407598013584665,0.488913099205332,0.029856666901110884,"['BST2', 'IQGAP1', 'HLA-E']",0.9921740875941403,0,0,3
369,Pathways Regulating Hippo Signaling WP4540,0.9455539328355427,0.42575879128225697,0.0238358295731136,"['PDGFRB', 'TEAD1']",0.9921740875941403,0,0,2
370,Pyrimidine metabolism WP4022,0.9455539328355427,0.42575879128225697,0.0238358295731136,"['POLD3', 'POLR1A']",0.9921740875941403,0,0,2
371,Cardiac Hypertrophic Response WP2795,0.9516652996957389,0.3263604746317512,0.01616851210994334,['NFATC2'],0.9921740875941403,0,0,1
372,RANKL/RANK signaling pathway WP2018,0.9516652996957389,0.3263604746317512,0.01616851210994334,['TRAF3'],0.9921740875941403,0,0,1
373,PI3K-Akt signaling pathway WP4172,0.954105230653518,0.5932568402471315,0.02787198289758314,"['PDGFRB', 'PPP2R2C', 'IRS1', 'PPP2R2B', 'ITGA7', 'COL9A2', 'SGK2', 'CREB5']",0.9921740875941403,0,0,8
374,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.954626976957254,0.31953625801282054,0.014837543071510566,['CTNNA1'],0.9921740875941403,0,0,1
375,Chemokine signaling pathway WP3929,0.9571624778875553,0.45477752594536563,0.019911125843708674,"['RAP1A', 'SHC1', 'ADCY8']",0.9921740875941403,0,0,3
376,Mitochondrial complex I assembly model OXPHOS system WP4324,0.9574073747169934,0.3129905808477237,0.013623321667075266,['NDUFAF2'],0.9921740875941403,0,0,1
377,Oxidative phosphorylation WP623,0.9574073747169934,0.3129905808477237,0.013623321667075266,['ATP5ME'],0.9921740875941403,0,0,1
378,G Protein Signaling Pathways WP35,0.9581039530340888,0.3979558347789395,0.017032110349659724,"['ADCY8', 'PDE7A']",0.9921740875941403,0,0,2
379,IL-1 signaling pathway WP195,0.9624679876865331,0.30066930618401205,0.011501945831221688,['HSPB2'],0.9921740875941403,0,0,1
380,Acute viral myocarditis WP4298,0.9647683801628187,0.2948640902366864,0.010575957261427486,['DFFA'],0.9921740875941403,0,0,1
381,TGF-beta Signaling Pathway WP366,0.9661600493756536,0.4331552625596726,0.01491170600310356,"['SHC1', 'PDK1', 'PIAS1']",0.9921740875941403,0,0,3
382,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.9669279276044676,0.28927793904209,0.00972879843246987,['MSH2'],0.9921740875941403,0,0,1
383,Regulatory circuits of the STAT3 signaling pathway WP4538,0.9669279276044676,0.28927793904209,0.00972879843246987,['PDGFRB'],0.9921740875941403,0,0,1
384,Endometrial cancer WP4155,0.9758967121759977,0.26423657161803715,0.006446982825177019,['CTNNA1'],0.9961750854160184,0,0,1
385,Toll-like Receptor Signaling Pathway WP75,0.9758967121759977,0.26423657161803715,0.006446982825177019,['TRAF3'],0.9961750854160184,0,0,1
386,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.9824351808975544,0.24317002442002442,0.004309194374291716,['MSH2'],0.9967745415789527,0,0,1
387,Sterol regulatory element-binding proteins (SREBP) signaling WP1982,0.9835126211722979,0.2393517127403846,0.003979176345363606,['SEC31A'],0.9967745415789527,0,0,1
388,Small cell lung cancer WP4658,0.9922889678665762,0.2013695597165992,0.0015587848192897494,['TRAF3'],0.9967745415789527,0,0,1
389,Pancreatic adenocarcinoma pathway WP4263,0.9927623273737253,0.19873876123876125,0.0014436367017716548,['ARHGEF6'],0.9967745415789527,0,0,1
390,Ectoderm Differentiation WP2858,0.9947145289707146,0.26566211479097995,0.0014078733344112635,"['HMGB2', 'PDE7A']",0.9967745415789527,0,0,2
391,ErbB signaling pathway WP673,0.9947275701219556,0.18654725609756098,0.0009861593452373217,['SHC1'],0.9967745415789527,0,0,1
392,Cytoplasmic Ribosomal Proteins WP477,0.9956404289807367,0.179920814479638,0.0007860923289870837,['RPS6KA3'],0.9967745415789527,0,0,1
393,IL-18 signaling pathway WP4754,0.9967745415789527,0.3385337086181477,0.0010936911787064237,"['PYGB', 'NR4A1', 'DEK', 'KLF2']",0.9967745415789527,0,0,4
